Cures Within Reach

GHRA 2018 Focus on Cancer Banner

Cures Within Reach held the 2018 Global Health Repurposing Awards

June 26 at City Winery in the West Loop

honoring leaders who have made a patient impact through cancer-related repurposing.

See photos from our 2018 Awards!

Looking for the 2019 GHRA page? Click here.

GHRA 2018 Awardees

❖ Novartis

Cures Within Reach Patient Impact Industry Award

selected for its strong support of repurposing imatinib, leading to FDA-approved therapies for several types of rare cancers, and providing nilotinib free of cost to researchers for clinical studies that may lead to regulatory approval in other conditions.
...

❖ The Leukemia & Lymphoma Society

Golan Christie Taglia Patient Impact Philanthropy Award

selected for being one of the earliest and leading major disease-specific nonprofits to fund repurposing research to complement its de novo research portfolio, and for partnering with academia, government and other philanthropic organizations to advance repurposing research as a way to drive treatments to patients with various blood cancers.
...

❖ Dr. Scott Weir, PharmD, PhD. University of Kansas Cancer Center

Janet Davison Rowley Patient Impact Research Award

selected for his work in advancing 12 repurposed drugs for cancer patients into clinical trials, as the co-inventor of a repurposed antifungal therapy to treat bladder cancer and as an acknowledged thought leader in the repurposing field. Watch the video below honoring Scott's research!

...